Glycozym Aps

Other

Margarida Amado

Henrik Clausen

A novel gene defining a novel enzyme in the UDP-D-galactose: &#x3b2;-N-acetylglucosamine / &#x3b2;-N-acetylgalactosamine &#x3b2;galactosyltransferase family, termed &#x3b2;Gal-T, with unique enzymatic properties is disclosed. The enzymatic activity of &#x3b2;Gal-Tis shown to be distinct from that of previously identified enzymes of this gene family. The invention discloses isolated DNA molecules and DNA constructs encoding &#x3b2;Gal-Tand derivatives thereof by way of amino acid deletion, substitution or insertion exhibiting &#x3b2;Gal-Tactivity, as well as cloning and expression vectors including such DNA, cells transfected with the vectors, and recombinant methods for providing &#x3b2;Gal-T. The enzyme &#x3b2;Gal-Tand &#x3b2;Gal-T-active derivatives thereof are disclosed, in particular soluble derivatives comprising the catalytically active domain of &#x3b2;Gal-T. Further, the invention discloses methods of obtaining &#x3b2;galactosyl glycosylated saccharides, glycopeptides or glycoproteins by use of an enzymatically active &#x3b2;Gal-Tprotein or, fusion protein thereof or by using cells stably transfected with a vector including DNA encoding an enzymatically active &#x3b2;Gal-Tprotein as an expression system for recombinant production of such glycopeptides or glycoproteins. Also a method for the identification of DNA sequence variations in the &#x3b2;Gal-Tgene by isolating DNA from a patient, amplifying &#x3b2;Gal-T-coding exons by PCR, and detecting the presence of DNA sequence variation, are disclosed.

[object Object]

A novel gene defining a novel enzyme in the UDP-D-galactose: beta-N-acetylglucosamine/beta-N-acetylgalactosamine beta 1,3galactosyltransferase family, termed beta3Gal-T5, with unique enzymatic properties is disclosed. The enzymatic activity of beta3Gal-T5 is shown to be distinct from that of previously identified enzymes of this gene family. The invention discloses isolated DNA molecules and DNA constructs encoding beta3Gal-T5 and derivatives thereof by way of amino acid deletion, substitution or insertion exhibiting beta3Gal-T5 activity, as well as cloning and expression vectors including such DNA, cells transfected with the vectors, and recombinant methods for providing beta3Gal-T5. The enzyme beta3Gal-T5 and beta3Gal-T5-active derivatives thereof are disclosed, in particular soluble derivatives comprising the catalytically active domain of beta3Gal-T5. Further, the invention discloses methods of obtaining beta 1,3galactosyl glycosylated saccharides, glycopeptides or glycoproteins by use of an enzymically active beta3Gal-T5 protein or fusion protein thereof or by using cells stably transfected with a vector including DNA encoding an enzymatically active beta3Gal-T5 protein as an expression system for recombinant production of such glycopeptides or glycoproteins. Also a method for the identification of DNA sequence variations in the beta3Gal-T5 gene by isolating DNA from a patient, amplifying beta3Gal-T5-coding exons by PCR, and detecting the presence of DNA sequence variation, are disclosed.

A novel gene defining a novel enzyme in the UDP-D-galactose: &bgr;-N-acetylglucosamine/&bgr;-N-acetylgalactosamine &bgr;1,3galactosyltransferase family, termed &bgr;3Gal-T5, with unique enzymatic properties is disclosed. The enzymatic activity of &bgr;3Gal-T5 is shown to be distinct from that of previously identified enzymes of this gene family. The invention discloses isolated DNA molecules and DNA constructs encoding &bgr;3Gal-T5 and derivatives thereof by way of amino acid deletion, substitution or insertion exhibiting &bgr;3Gal-T5 activity, as well as cloning and expression vectors including such DNA, cells tranfected with the vectors, and recombinant methods for providing &bgr;3Gal-T5. The enzyme &bgr;3Gal-T5 and &bgr;3Gal-T5-active derivatives thereof are disclosed, in particular soluble derivatives comprising the catalytically active domain of &bgr;3Gal-T5. Further, the invention discloses methods of obtaining &bgr;1,3galactosyl glycosylated saccharides, glycopeptides or glycoproteins by use of an enzymically active &bgr;3Gal-T5 protein or fusion protein thereof or by using cells stably transfected with a vector including DNA encoding an enzymatically active &bgr;3Gal-T5 protein as an expression system for recombinant production of such glycopeptides or glycoproteins. Also a method for the identification of DNA sequence variations in the &bgr;3Gal-T5 gene by isolating DNA from a patient, amplifying &bgr;3Gal-T5-coding exons by PCR, and detecting the presence of DNA sequence variation, are disclosed.

Growing community of inventors

La Jolla, CA, United States of America

Margarida Amado